Molecular Oncology
Volume 3, Issue 5 , Pages 389-391, December 2009

Tailoring cancer therapy – Validating basic science with the ‘supertrial’

published online 28 August 2009.

Abstract 

A paradigm shift in research culture is needed in order to set up the large ambitious trials needed to make personalised medicine a reality. Emma Wilkinson talks to the experts about the hurdles they face and what needs to change.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1574-7891(09)00109-4

doi:10.1016/j.molonc.2009.08.001

Molecular Oncology
Volume 3, Issue 5 , Pages 389-391, December 2009

Article Tools

* Image Usage & Resolution